What new therapeutic targets exist for EGFR-mutant NSCLC?

被引：5

作者：

Rosell, Rafael ^{[1
]}

机构：

[1] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Canc Biol & Precis Med Program, Barcelona, Spain

来源：

LANCET ONCOLOGY | 2014年 / 15卷 / 11期

关键词：

CELL LUNG-CANCER; ERLOTINIB; CHEMOTHERAPY; MUTATIONS; EURTAC; TRIAL; MET;

D O I：

10.1016/S1470-2045(14)70386-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1184 / 1185

页数：3

共 10 条

[1]

[Anonymous], LANCET ONCOL

[2] The Impact of EGFR T790M Mutations and BIM mRNA Expression on Outcome in Patients with EGFR-Mutant NSCLC Treated with Erlotinib or Chemotherapy in the Randomized Phase III EURTAC Trial [J].

Costa, Carlota ;

Molina, Miguel Angel ;

Drozdowskyj, Ana ;

Gimenez-Capitan, Ana ;

Bertran-Alamillo, Jordi ;

Karachaliou, Niki ;

Gervais, Radj ;

Massuti, Bartomeu ;

Wei, Jia ;

Moran, Teresa ;

Majem, Margarita ;

Felip, Enriqueta ;

Carcereny, Enric ;

Garcia-Campelo, Rosario ;

Viteri, Santiago ;

Taron, Miquel ;

Ono, Mayumi ;

Giannikopoulos, Petros ;

Bivona, Trever ;

Rosell, Rafael .

CLINICAL CANCER RESEARCH, 2014, 20 (07) :2001-2010

[3] Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors [J].

Croci, Diego O. ;

Cerliani, Juan P. ;

Dalotto-Moreno, Tomas ;

Mendez-Huergo, Santiago P. ;

Mascanfroni, Ivan D. ;

Dergan-Dylon, Sebastian ;

Toscano, Marta A. ;

Caramelo, Julio J. ;

Garcia-Vallejo, Juan J. ;

Ouyang, Jing ;

Mesri, Enrique A. ;

Junttila, Melissa R. ;

Bais, Carlos ;

Shipp, Margaret A. ;

Salatino, Mariana ;

Rabinovich, Gabriel A. .

CELL, 2014, 156 (04) :744-758

[4] MET-Independent Lung Cancer Cells Evading EGFR Kinase Inhibitors Are Therapeutically Susceptible to BH3 Mimetic Agents [J].

Fan, Weiwen ;

Tang, Zhe ;

Yin, Lihong ;

Morrison, Bei ;

Hafez-Khayyata, Said ;

Fu, Pingfu ;

Huang, Honglian ;

Bagai, Rakesh ;

Jiang, Shan ;

Kresak, Adam ;

Howell, Scott ;

Vasanji, Amit ;

Flask, Chris A. ;

Halmos, Balazs ;

Koon, Henry ;

Ma, Patrick C. .

CANCER RESEARCH, 2011, 71 (13) :4494-4505

[5] Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non-Small Cell Lung Cancer [J].

Li, Rui ;

Hu, Zhongliang ;

Sun, Shi-Yong ;

Chen, Zhuo G. ;

Owonikoko, Taofeek K. ;

Sica, Gabriel L. ;

Ramalingam, Suresh S. ;

Curran, Walter J. ;

Khuri, Fadlo R. ;

Deng, Xingming .

MOLECULAR CANCER THERAPEUTICS, 2013, 12 (10) :2200-2212

[6] VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex [J].

Lu, Kan V. ;

Chang, Jeffrey P. ;

Parachoniak, Christine A. ;

Pandika, Melissa M. ;

Aghi, Manish K. ;

Meyronet, David ;

Isachenko, Nadezda ;

Fouse, Shaun D. ;

Phillips, Joanna J. ;

Cheresh, David A. ;

Park, Morag ;

Bergers, Gabriele .

CANCER CELL, 2012, 22 (01) :21-35

[7] Triple Inhibition of EGFR, Met, and VEGF Suppresses Regrowth of HGF-Triggered, Erlotinib-Resistant Lung Cancer Harboring an EGFR Mutation [J].

Nakade, Junya ;

Takeuchi, Shinji ;

Nakagawa, Takayuki ;

Ishikawa, Daisuke ;

Sano, Takako ;

Nanjo, Shigeki ;

Yamada, Tadaaki ;

Ebi, Hiromichi ;

Zhao, Lu ;

Yasumoto, Kazuo ;

Matsumoto, Kunio ;

Yonekura, Kazuhiko ;

Yano, Seiji .

JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (06) :775-783

[8] Genetics and biomarkers in personalisation of lung cancer treatment [J].

Rosell, Rafael ;

Bivona, Trever G. ;

Karachaliou, Niki .

LANCET, 2013, 382 (9893) :720-731

[9] Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial [J].

Rosell, Rafael ;

Carcereny, Enric ;

Gervais, Radj ;

Vergnenegre, Alain ;

Massuti, Bartomeu ;

Felip, Enriqueta ;

Palmero, Ramon ;

Garcia-Gomez, Ramon ;

Pallares, Cinta ;

Miguel Sanchez, Jose ;

Porta, Rut ;

Cobo, Manuel ;

Garrido, Pilar ;

Longo, Flavia ;

Moran, Teresa ;

Insa, Amelia ;

De Marinis, Filippo ;

Corre, Romain ;

Bover, Isabel ;

Illiano, Alfonso ;

Dansin, Eric ;

de Castro, Javier ;

Milella, Michele ;

Reguart, Noemi ;

Altavilla, Giuseppe ;

Jimenez, Ulpiano ;

Provencio, Mariano ;

Angel Moreno, Miguel ;

Terrasa, Josefa ;

Munoz-Langa, Jose ;

Valdivia, Javier ;

Isla, Dolores ;

Domine, Manuel ;

Molinier, Olivier ;

Mazieres, Julien ;

Baize, Nathalie ;

Garcia-Campelo, Rosario ;

Robinet, Gilles ;

Rodriguez-Abreu, Delvys ;

Lopez-Vivanco, Guillermo ;

Gebbia, Vittorio ;

Ferrera-Delgado, Lioba ;

Bombaron, Pierre ;

Bernabe, Reyes ;

Bearz, Alessandra ;

Artal, Angel ;

Cortesi, Enrico ;

Rolfo, Christian ;

Sanchez-Ronco, Maria ;

Drozdowskyj, Ana .

LANCET ONCOLOGY, 2012, 13 (03) :239-246

[10] Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways [J].

Sordella, R ;

Bell, DW ;

Haber, DA ;

Settleman, J .

SCIENCE, 2004, 305 (5687) :1163-1167

← 1 →